These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10731038)

  • 21. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
    Németh B; Ledent C; Freund TF; Hájos N
    Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid modulation of intestinal propulsion in mice.
    Colombo G; Agabio R; Lobina C; Reali R; Gessa GL
    Eur J Pharmacol; 1998 Feb; 344(1):67-9. PubMed ID: 9570450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
    Kathmann M; Bauer U; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
    Guo J; Ikeda SR
    Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
    Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
    J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
    Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
    Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
    Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
    J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.
    Wilson RI; Nicoll RA
    Nature; 2001 Mar; 410(6828):588-92. PubMed ID: 11279497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
    Gessa GL; Mascia MS; Casu MA; Carta G
    Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
    Lees G; Dougalis A
    Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
    Mendiguren A; Pineda J
    Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
    Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC
    Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
    Tyler K; Hillard CJ; Greenwood-Van Meerveld B
    Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
    Lauckner JE; Hille B; Mackie K
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.